The impact of the COVID-19 pandemic on antimicrobial usage: An international patient-level cohort study
Farzana R. et al, (2025), JAC-Antimicrobial Resistance, 7
Benefits of aldosterone receptor antagonism in chronic kidney disease: the BARACK-D RCT
Hobbs FDR. et al, (2025), Health Technology Assessment, 29
Self-monitoring of blood pressure following a stroke or transient ischaemic attack (TASMIN5S): a randomised controlled trial
McManus RJ. et al, (2024), BMC Cardiovascular Disorders, 24
Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial
Farmer AJ. et al, (2024), Pilot and Feasibility Studies, 10
User engagement in clinical trials of digital mental health interventions: a systematic review
Elkes J. et al, (2024), BMC Medical Research Methodology, 24
Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stage
Toader AM. et al, (2024), Trials, 25
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Hobbs FR. et al, (2024), Journal of Infection, 89
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial
Sheppard JP. et al, (2024), The Lancet Healthy Longevity, 5, e563 - e573
Nurse-delivered sleep restriction therapy to improve insomnia disorder in primary care: the HABIT RCT
Kyle SD. et al, (2024), Health Technology Assessment, 28
FOUND Trial: randomised controlled trial study protocol for case finding of obstructive sleep apnoea in primary care using a novel device
Miller MA. et al, (2024), BMJ Open, 14
Effect of antihypertensive deprescribing on serious adverse events, mortality, and cardiovascular disease: Long-term follow-up of the OPTiMISE randomised controlled trial
SHEPPARD J. et al, (2024), The Lancet Healthy Longevity
Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiology
Martin NG. et al, (2024), Journal of Infection, 88
Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT
Iro MA. et al, (2024), Efficacy and Mechanism Evaluation, 1 - 53
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Hayward G. et al, (2024), Journal of Infection, 88
Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland: a pragmatic, non-inferiority, clinical effectiveness and cost-effectiveness randomised controlled trial
Creswell C. et al, (2024), The Lancet Psychiatry, 11, 193 - 209
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
Standing JF. et al, (2024), Nature communications, 15